Application of industrial scale genomics to discovery of therapeutic targets in heart failure

European Journal of Heart Failure

Volumn 3, Issue 6, 2001, Pages 641-650

  Mehraban, Fuad ^a   Tomlinson, James E ^b  

^a CURAGEN CORPORATION   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Cardiovascular disease; Drug discovery; Expression profiling; Genomics

Indexed keywords

DEXFENFLURAMINE; DIHYDROERGOTAMINE; FENFLURAMINE; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; SUMATRIPTAN;

ANIMAL TISSUE; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; DISEASE PREDISPOSITION; DNA SEQUENCE; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC POLYMORPHISM; GENOME; HEART FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VALVULAR HEART DISEASE;

DATABASES, GENETIC; DRUG DESIGN; GENE EXPRESSION; GENOMICS; HEART FAILURE, CONGESTIVE; HUMANS; OCCUPATIONAL MEDICINE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME;

EID: 0035203541     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00203-3     Document Type: Review

References (45)

1. Analysis of expressed sequence tags indicates 35,000 human genes
2. Gene index analysis of the human genome estimates approximately 120,000 genes
3. The EMBL nucleotide sequence database
4. MIPS: A database for genomes and protein sequences
5. Serial analysis of gene expression
6. Gene expression analysis by transcript profiling coupled to a gene database query
7. TOGA: An automated parsing technology for analyzing expression of nearly all genes
8. Light-generated oligonucleotide arrays for rapid DNA sequence analysis
9. Open systems: Panoramic views of gene expression
10. DNA chips: An array of possibilities
11. Cardiomyopathy induced by cardiac Gs alpha overexpression
12. Apoptosis of cardiac myocytes in Gs alpha transgenic mice
13. GeneCalling yields new insights into mechanism of cardiomyopathy in mice overexpressing Gsα in the heart
14. Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus
15. Altered patterns of gene expression in response to myocardial infarction
16. The Tangier disease gene product ABC1 controls the cellular apolipoproteinmediated lipid removal pathway
17. A genome-based resource for molecular cardiovascular medicine: Toward a compendium of cardiovascular genes
18. Base-calling of automated sequencer traces using phred. I. Accuracy assessment
19. Base-calling of automated sequencer traces using phred. II. Error probabilities
20. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine
21. The use of animal models in expression pharmacogenomic analysis
22. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene
23. Sequence diversity and large-scale typing of SNPs in human apolipoprotein E gene
24. Sequence variation in the human angiotensin converting enzyme
25. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects
26. Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype
27. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism
28. Angiotensin I converting enzyme gene polymorphism and coronary heart disease
29. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease
30. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction
31. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
32. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
33. Lack of association of angiotensin converting enzyme gene polymorphism or serum enzyme activity with coronary artery disease in Japanese subjects
34. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease
35. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis
36. Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension
37. Pharmacogenomics: Translating functional genomics into rational therapeutics
38. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae